174 related articles for article (PubMed ID: 27586082)
1. Novel diindolylmethane derivatives based NLC formulations to improve the oral bioavailability and anticancer effects in triple negative breast cancer.
Godugu C; Doddapaneni R; Safe SH; Singh M
Eur J Pharm Biopharm; 2016 Nov; 108():168-179. PubMed ID: 27586082
[TBL] [Abstract][Full Text] [Related]
2. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).
Godugu C; Doddapaneni R; Singh M
Colloids Surf B Biointerfaces; 2017 May; 153():208-219. PubMed ID: 28249200
[TBL] [Abstract][Full Text] [Related]
3. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
4. Lipid-based oral delivery systems for skin deposition of a potential chemopreventive DIM derivative: characterization and evaluation.
Boakye CH; Patel K; Patel AR; Faria HA; Zucolotto V; Safe S; Singh M
Drug Deliv Transl Res; 2016 Oct; 6(5):526-39. PubMed ID: 27405772
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of self-emulsified DIM-14 in dogs for oral bioavailability and in Nu/nu mice bearing stem cell lung tumor models for anticancer activity.
Patel AR; Doddapaneni R; Andey T; Wilson H; Safe S; Singh M
J Control Release; 2015 Sep; 213():18-26. PubMed ID: 26079185
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Spray BIO-Max DIM-P in Dogs for Oral Bioavailability and in Nu/nu Mice Bearing Orthotopic/Metastatic Lung Tumor Models for Anticancer Activity.
Patel AR; Godugu C; Wilson H; Safe S; Singh M
Pharm Res; 2015 Jul; 32(7):2292-300. PubMed ID: 25576245
[TBL] [Abstract][Full Text] [Related]
7. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
Khan S; Baboota S; Ali J; Narang RS; Narang JK
Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
[TBL] [Abstract][Full Text] [Related]
8. PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A.
Wang L; Luo Q; Lin T; Li R; Zhu T; Zhou K; Ji Z; Song J; Jia B; Zhang C; Chen W; Zhu G
Drug Dev Ind Pharm; 2015; 41(7):1204-12. PubMed ID: 25010850
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic evaluation and in vitro-in vivo correlation (IVIVC) of novel methylene-substituted 3,3' diindolylmethane (DIM).
Patel AR; Spencer SD; Chougule MB; Safe S; Singh M
Eur J Pharm Sci; 2012 May; 46(1-2):8-16. PubMed ID: 22342559
[TBL] [Abstract][Full Text] [Related]
10. Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma.
Godugu C; Doddapaneni R; Patel AR; Singh R; Mercer R; Singh M
Pharm Res; 2016 Jan; 33(1):137-54. PubMed ID: 26286185
[TBL] [Abstract][Full Text] [Related]
11. Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid.
Godugu C; Patel AR; Doddapaneni R; Somagoni J; Singh M
PLoS One; 2014; 9(3):e89919. PubMed ID: 24614362
[TBL] [Abstract][Full Text] [Related]
12. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
Li H; Chen M; Su Z; Sun M; Ping Q
Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
[TBL] [Abstract][Full Text] [Related]
13. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats.
Zhang S; Wang J; Pan J
Drug Deliv; 2016 Nov; 23(9):3696-3703. PubMed ID: 27749105
[TBL] [Abstract][Full Text] [Related]
14. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus-loaded nanostructured lipid carriers for oral delivery-in vivo bioavailability enhancement.
Khan S; Shaharyar M; Fazil M; Hassan MQ; Baboota S; Ali J
Eur J Pharm Biopharm; 2016 Dec; 109():149-157. PubMed ID: 27793753
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
Zhuang CY; Li N; Wang M; Zhang XN; Pan WS; Peng JJ; Pan YS; Tang X
Int J Pharm; 2010 Jul; 394(1-2):179-85. PubMed ID: 20471464
[TBL] [Abstract][Full Text] [Related]
17. Quality by design approach to understand the process of optimization of iloperidone nanostructured lipid carriers for oral bioavailability enhancement.
Mandpe L; Pokharkar V
Pharm Dev Technol; 2015 May; 20(3):320-9. PubMed ID: 24328553
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption.
Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B
Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104
[TBL] [Abstract][Full Text] [Related]
19. Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel.
Sun B; Luo C; Li L; Wang M; Du Y; Di D; Zhang D; Ren G; Pan X; Fu Q; Sun J; He Z
Colloids Surf B Biointerfaces; 2016 Jul; 143():47-55. PubMed ID: 27011346
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured lipid carriers as a delivery system of biochanin A.
Wang Q; Cheng H; Zhou K; Wang L; Dong S; Wang D; Chen W
Drug Deliv; 2013 Nov; 20(8):331-7. PubMed ID: 24111887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
